Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
19 April 2023 | Story Nonkululeko Nxumalo | Photo Supplied
TSOHO ‘The Awakening’
TSOHO ‘The Awakening’ – available at the UFS library.


In celebration of linguistic diversity and the power of creative expression, the University of the Free State (UFS) African Languages Press and the Academy for Multilingualism launched a new seminal book, TSOHO 'The Awakening', on 14 April 2023.

This anthology of poetry and short stories stems from the first cohort of authors who participated in the Creative Writing Multilingual Hub masterclasses held in July 2022 with Ntabiseng Jafta, Publishing Coordinator at the African Languages Press; Dr Jerry Mofokeng wa Makgetha, author and award-winning South African actor; Dr Mathene Mahanke, Free State Head of Provincial Language Services; and Dr Elias Malete, Senior Lecturer and Academic Head in the Department of African Languages

What sets this collection apart is that the students took pride in expressing themselves in not just one, but seven indigenous South African languages, showcasing the rich tapestry of cultures and traditions that make up this vibrant nation.

“We hope that this launch will not only inspire you to read, but also to write, especially in indigenous languages. In that way, we can preserve, promote, and develop our African languages,” Dina Mashiyane: Head Librarian in the UFS Library and Information Services (LIS), highlighted during her welcoming speech.

In her message of support, the words of the Director of the Academy for Multilingualism, Dr Nomalungelo Ngubane, echoed the significance of this book, not just as a celebration of creativity and multilingualism, but also as a seed of inspiration that has the potential to grow. “Other young writers will look at you and take that initiative as well, standing proud in their languages,” she added.

Bangodi ‘The Authors’

The authors, whose names are a testament to their unique identities and backgrounds, include Ontlametse Manana Mothobi, Judith Tladi, Paseka Mathonsi, Langelihle Button, Celuxolo Mthembu, Kesaobaka Ncubuka, Modiehi Motseko, Ciliciah Chagane, Siphilangekhosi Dlamini, Tshegofatso Sello Kitso, Tlotlisang David Mhlambiso, and Balisa Nqambuza. These diverse voices are woven together in this anthology to create a symphony of words that will resonate with readers of all backgrounds.

Augmented Reality Feature

TSOHO is not just any ordinary book. With assistance from Thuthukani Ndlovu, augmented reality developer and alumnus of the UFS, this anthology is an innovative work that pushes the boundaries of traditional literature, embracing the digital age with an augmented reality feature that brings the pages to life.
 
Through the Artivive app, readers can experience a digital journey, where images in the book come alive with audio recitals in vernac. This unique fusion of traditional storytelling and modern technology is a testament to the innovative thinking of the African Languages Press, which seeks to promote and preserve indigenous languages across all spheres of human interaction.

Inspiration behind the title

When asked about the inspiration behind the title, Jafta had this to say, “We wanted them to wake up to themselves. To know that they have it within them to express and write in many languages. We have languages, they’re ours and they’re engraved within our DNA. We just wanted them to go into an experience of realisation, of discovery, but mostly to have that moment of awakening to say I too can. That’s why I came up with this title.”

Jafta also mentioned that there would be future cohorts, “This is our first offering, there are still more to come. We’re going to have our second cohort, so be on the lookout, they will be advertising for the next one,” she said.
 
The book can be found at the UFS library and will soon be available at Exclusive Books. 

News Archive

Nuclear Medicine on the forefront of cancer research
2017-07-10

Description: Nuclear Medicine on the forefront of cancer research Tags: Nuclear Medicine, cancer research, Dr Je’nine Horn-Lodewyk’s, tumour detection method, cancer, Department of Nuclear Medicine 

Dr Je’nine Horn-Lodewyk’s tumour detection method
could be the cost-effective breakthrough needed to decrease
the mortality rate in breast cancer patients.
Photo: Anja Aucamp

The field of Nuclear Medicine in South Africa and the rest of the world are expanding rapidly due to the development of hybrid cameras and new radiopharmaceuticals. These developments have a huge impact on the diagnosis and therapy of cancer.

The most advanced of these cameras, Positron emission tomography combined with normal CTs (PETCT), are not yet widely available in South Africa due to the cost of the cameras and the radiopharmaceuticals. A more cost-effective alternative can be of great benefit. To achieve this, the focus should be on developing new radiopharmaceuticals that can be used with the current cost-effective gamma cameras, according to University of the Free State researcher, Dr Je’nine Horn-Lodewyk from the Department of Nuclear Medicine.

Fluorodeoxyglucose (18F-FDG), a radiolabelled glucose analogue, is currently the radiopharmaceutical most commonly used in PET/CT imaging for mainly oncology indications. Although it is considered the gold standard for imaging in several malignancies, it does have certain disadvantages. An 18F-FDG PET/CT diagnostic imaging study can cost between R25 000 and R35 000 for a single patient in the private sector. The 18F-FDG is also more radioactive, which requires much stricter handling and shielding to avoid high radiation dosages to staff and patients.

Successful research potential innovative solution
In the search for the ideal radiopharmaceutical for tumour detection, the South African National Nuclear Energy Corporation (Necsa) developed a local synthesis process for ethylenedicysteine-deoxyglucose (EC-DG). EC-DG is also a glucose analogue similar to FDG. They succeeded in labelling the compound with Technetium-99-metastable-pertechnetate (99mTcO4-), the most common nuclear medicine isotope used for approximately 95% of nuclear medicine procedures, creating 99mTc-EC-DG.

In partnership with Dr Horn-Lodewyk, this compound was successfully used in various animal models and clinical scenarios, resulting in approval by the Medicine Control Council to use it in a human study. Research is also planned in order to investigate diagnostic accuracy in other cancers like lymphoma.  The end result of this research can produce a radiopharmaceutical that is cost effective, does not require the use of costly specialised equipment, has no significant side-effects, no special patient preparation, renders late imaging possible, and has decreased radiation risks.

Dr Horn-Lodewyk is grateful for the support of her mentor, Prof Anton Otto, as well as Dr Gert Engelbrecht, Head of the Department of Nuclear Medicine, Prof Jan Rijn Zeevaart from North-West University’s Preclinical Drug Development Platform and Necsa, and Judith Wagener from Necsa. This innovative research would also not have been possible without the financial assistance of Dr Glen Taylor and Eleanor van der Westhuizen in the Directorate of Research Development.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept